Form 8-K - Current report:
SEC Accession No. 0001437749-26-016724
Filing Date
2026-05-13
Accepted
2026-05-13 16:10:24
Documents
14
Period of Report
2026-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20260511_8k.htm   iXBRL 8-K 29334
2 EXHIBIT 99.1 ex_960711.htm EX-99.1 100368
7 logo.jpg GRAPHIC 2995
  Complete submission text file 0001437749-26-016724.txt   275068

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tlph-20260513.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20260513_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20260513_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20260513_pre.xml EX-101.PRE 11584
17 EXTRACTED XBRL INSTANCE DOCUMENT acrx20260511_8k_htm.xml XML 2838
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 412193603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 26973343
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)